Global Nuclear Medicine Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 198549
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Nuclear Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Nuclear Medicine size is estimated to be USD 7796.2 million in 2026 from USD 5929.5 million in 2020, with a change XX% between 2020 and 2021. The global Nuclear Medicine market size is expected to grow at a CAGR of 7.1% for the next five years.

Market segmentation

Nuclear Medicine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Tc-99

I-123/131

In-111

Xe-133

Th-201

Ga-67

Others

Market segment by Application, can be divided into

Diagnostic

Therapeutic

Market segment by players, this report covers

GE Healthcare

Bracco Imaging

Mallinckrodt

Lantheus Medical Imaging

Bayer

Triad Isotopes

Nordion

Jubilant Pharma

Eli Lilly

SIEMENS

China Isotope & Radiation

Dongcheng

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Nuclear Medicine

1.2 Classification of Nuclear Medicine by Type

1.2.1 Overview: Global Nuclear Medicine Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Nuclear Medicine Revenue Market Share by Type in 2020

1.2.3 Tc-99

1.2.4 I-123/131

1.2.5 In-111

1.2.6 Xe-133

1.2.7 Th-201

1.2.8 Ga-67

1.2.9 Others

1.3 Global Nuclear Medicine Market by Application

1.3.1 Overview: Global Nuclear Medicine Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Diagnostic

1.3.3 Therapeutic

1.4 Global Nuclear Medicine Market Size & Forecast

1.5 Global Nuclear Medicine Market Size and Forecast by Region

1.5.1 Global Nuclear Medicine Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Nuclear Medicine Market Size by Region, (2016-2021)

1.5.3 North America Nuclear Medicine Market Size and Prospect (2016-2026)

1.5.4 Europe Nuclear Medicine Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Nuclear Medicine Market Size and Prospect (2016-2026)

1.5.6 South America Nuclear Medicine Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Nuclear Medicine Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Nuclear Medicine Market Drivers

1.6.2 Nuclear Medicine Market Restraints

1.6.3 Nuclear Medicine Trends Analysis

2 Company Profiles

2.1 GE Healthcare

2.1.1 GE Healthcare Details

2.1.2 GE Healthcare Major Business

2.1.3 GE Healthcare Nuclear Medicine Product and Solutions

2.1.4 GE Healthcare Nuclear Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 GE Healthcare Recent Developments and Future Plans

2.2 Bracco Imaging

2.2.1 Bracco Imaging Details

2.2.2 Bracco Imaging Major Business

2.2.3 Bracco Imaging Nuclear Medicine Product and Solutions

2.2.4 Bracco Imaging Nuclear Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Bracco Imaging Recent Developments and Future Plans

2.3 Mallinckrodt

2.3.1 Mallinckrodt Details

2.3.2 Mallinckrodt Major Business

2.3.3 Mallinckrodt Nuclear Medicine Product and Solutions

2.3.4 Mallinckrodt Nuclear Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Mallinckrodt Recent Developments and Future Plans

2.4 Lantheus Medical Imaging

2.4.1 Lantheus Medical Imaging Details

2.4.2 Lantheus Medical Imaging Major Business

2.4.3 Lantheus Medical Imaging Nuclear Medicine Product and Solutions

2.4.4 Lantheus Medical Imaging Nuclear Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Lantheus Medical Imaging Recent Developments and Future Plans

2.5 Bayer

2.5.1 Bayer Details

2.5.2 Bayer Major Business

2.5.3 Bayer Nuclear Medicine Product and Solutions

2.5.4 Bayer Nuclear Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Bayer Recent Developments and Future Plans

2.6 Triad Isotopes

2.6.1 Triad Isotopes Details

2.6.2 Triad Isotopes Major Business

2.6.3 Triad Isotopes Nuclear Medicine Product and Solutions

2.6.4 Triad Isotopes Nuclear Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Triad Isotopes Recent Developments and Future Plans

2.7 Nordion

2.7.1 Nordion Details

2.7.2 Nordion Major Business

2.7.3 Nordion Nuclear Medicine Product and Solutions

2.7.4 Nordion Nuclear Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Nordion Recent Developments and Future Plans

2.8 Jubilant Pharma

2.8.1 Jubilant Pharma Details

2.8.2 Jubilant Pharma Major Business

2.8.3 Jubilant Pharma Nuclear Medicine Product and Solutions

2.8.4 Jubilant Pharma Nuclear Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Jubilant Pharma Recent Developments and Future Plans

2.9 Eli Lilly

2.9.1 Eli Lilly Details

2.9.2 Eli Lilly Major Business

2.9.3 Eli Lilly Nuclear Medicine Product and Solutions

2.9.4 Eli Lilly Nuclear Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Eli Lilly Recent Developments and Future Plans

2.10 SIEMENS

2.10.1 SIEMENS Details

2.10.2 SIEMENS Major Business

2.10.3 SIEMENS Nuclear Medicine Product and Solutions

2.10.4 SIEMENS Nuclear Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 SIEMENS Recent Developments and Future Plans

2.11 China Isotope & Radiation

2.11.1 China Isotope & Radiation Details

2.11.2 China Isotope & Radiation Major Business

2.11.3 China Isotope & Radiation Nuclear Medicine Product and Solutions

2.11.4 China Isotope & Radiation Nuclear Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 China Isotope & Radiation Recent Developments and Future Plans

2.12 Dongcheng

2.12.1 Dongcheng Details

2.12.2 Dongcheng Major Business

2.12.3 Dongcheng Nuclear Medicine Product and Solutions

2.12.4 Dongcheng Nuclear Medicine Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Dongcheng Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Nuclear Medicine Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Nuclear Medicine Players Market Share

3.2.2 Top 10 Nuclear Medicine Players Market Share

3.2.3 Market Competition Trend

3.3 Nuclear Medicine Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Nuclear Medicine Revenue and Market Share by Type (2016-2021)

4.2 Global Nuclear Medicine Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Nuclear Medicine Revenue Market Share by Application (2016-2021)

5.2 Nuclear Medicine Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Nuclear Medicine Revenue by Type (2016-2026)

6.2 North America Nuclear Medicine Revenue by Application (2016-2026)

6.3 North America Nuclear Medicine Market Size by Country

6.3.1 North America Nuclear Medicine Revenue by Country (2016-2026)

6.3.2 United States Nuclear Medicine Market Size and Forecast (2016-2026)

6.3.3 Canada Nuclear Medicine Market Size and Forecast (2016-2026)

6.3.4 Mexico Nuclear Medicine Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Nuclear Medicine Revenue by Type (2016-2026)

7.2 Europe Nuclear Medicine Revenue by Application (2016-2026)

7.3 Europe Nuclear Medicine Market Size by Country

7.3.1 Europe Nuclear Medicine Revenue by Country (2016-2026)

7.3.2 Germany Nuclear Medicine Market Size and Forecast (2016-2026)

7.3.3 France Nuclear Medicine Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Nuclear Medicine Market Size and Forecast (2016-2026)

7.3.5 Russia Nuclear Medicine Market Size and Forecast (2016-2026)

7.3.6 Italy Nuclear Medicine Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Nuclear Medicine Revenue by Type (2016-2026)

8.2 Asia-Pacific Nuclear Medicine Revenue by Application (2016-2026)

8.3 Asia-Pacific Nuclear Medicine Market Size by Region

8.3.1 Asia-Pacific Nuclear Medicine Revenue by Region (2016-2026)

8.3.2 China Nuclear Medicine Market Size and Forecast (2016-2026)

8.3.3 Japan Nuclear Medicine Market Size and Forecast (2016-2026)

8.3.4 South Korea Nuclear Medicine Market Size and Forecast (2016-2026)

8.3.5 India Nuclear Medicine Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Nuclear Medicine Market Size and Forecast (2016-2026)

8.3.7 Australia Nuclear Medicine Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Nuclear Medicine Revenue by Type (2016-2026)

9.2 South America Nuclear Medicine Revenue by Application (2016-2026)

9.3 South America Nuclear Medicine Market Size by Country

9.3.1 South America Nuclear Medicine Revenue by Country (2016-2026)

9.3.2 Brazil Nuclear Medicine Market Size and Forecast (2016-2026)

9.3.3 Argentina Nuclear Medicine Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Nuclear Medicine Revenue by Type (2016-2026)

10.2 Middle East & Africa Nuclear Medicine Revenue by Application (2016-2026)

10.3 Middle East & Africa Nuclear Medicine Market Size by Country

10.3.1 Middle East & Africa Nuclear Medicine Revenue by Country (2016-2026)

10.3.2 Turkey Nuclear Medicine Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Nuclear Medicine Market Size and Forecast (2016-2026)

10.3.4 UAE Nuclear Medicine Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Nuclear Medicine Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Nuclear Medicine Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Nuclear Medicine Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Nuclear Medicine Revenue (USD Million) by Region (2016-2021)

Table 5. Global Nuclear Medicine Revenue Market Share by Region (2021-2026)

Table 6. GE Healthcare Corporate Information, Head Office, and Major Competitors

Table 7. GE Healthcare Major Business

Table 8. GE Healthcare Nuclear Medicine Product and Solutions

Table 9. GE Healthcare Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Bracco Imaging Corporate Information, Head Office, and Major Competitors

Table 11. Bracco Imaging Major Business

Table 12. Bracco Imaging Nuclear Medicine Product and Solutions

Table 13. Bracco Imaging Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Mallinckrodt Corporate Information, Head Office, and Major Competitors

Table 15. Mallinckrodt Major Business

Table 16. Mallinckrodt Nuclear Medicine Product and Solutions

Table 17. Mallinckrodt Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Lantheus Medical Imaging Corporate Information, Head Office, and Major Competitors

Table 19. Lantheus Medical Imaging Major Business

Table 20. Lantheus Medical Imaging Nuclear Medicine Product and Solutions

Table 21. Lantheus Medical Imaging Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Bayer Corporate Information, Head Office, and Major Competitors

Table 23. Bayer Major Business

Table 24. Bayer Nuclear Medicine Product and Solutions

Table 25. Bayer Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Triad Isotopes Corporate Information, Head Office, and Major Competitors

Table 27. Triad Isotopes Major Business

Table 28. Triad Isotopes Nuclear Medicine Product and Solutions

Table 29. Triad Isotopes Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Nordion Corporate Information, Head Office, and Major Competitors

Table 31. Nordion Major Business

Table 32. Nordion Nuclear Medicine Product and Solutions

Table 33. Nordion Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Jubilant Pharma Corporate Information, Head Office, and Major Competitors

Table 35. Jubilant Pharma Major Business

Table 36. Jubilant Pharma Nuclear Medicine Product and Solutions

Table 37. Jubilant Pharma Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Eli Lilly Corporate Information, Head Office, and Major Competitors

Table 39. Eli Lilly Major Business

Table 40. Eli Lilly Nuclear Medicine Product and Solutions

Table 41. Eli Lilly Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. SIEMENS Corporate Information, Head Office, and Major Competitors

Table 43. SIEMENS Major Business

Table 44. SIEMENS Nuclear Medicine Product and Solutions

Table 45. SIEMENS Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. China Isotope & Radiation Corporate Information, Head Office, and Major Competitors

Table 47. China Isotope & Radiation Major Business

Table 48. China Isotope & Radiation Nuclear Medicine Product and Solutions

Table 49. China Isotope & Radiation Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Dongcheng Corporate Information, Head Office, and Major Competitors

Table 51. Dongcheng Major Business

Table 52. Dongcheng Nuclear Medicine Product and Solutions

Table 53. Dongcheng Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Global Nuclear Medicine Revenue (USD Million) by Players (2019-2021)

Table 55. Global Nuclear Medicine Revenue Share by Players (2019-2021)

Table 56. Breakdown of Nuclear Medicine by Company Type (Tier 1, Tier 2 and Tier 3)

Table 57. Nuclear Medicine Players Head Office, Products and Services Provided

Table 58. Nuclear Medicine Mergers & Acquisitions in the Past Five Years

Table 59. Nuclear Medicine New Entrants and Expansion Plans

Table 60. Global Nuclear Medicine Revenue (USD Million) by Type (2016-2021)

Table 61. Global Nuclear Medicine Revenue Share by Type (2016-2021)

Table 62. Global Nuclear Medicine Revenue Forecast by Type (2021-2026)

Table 63. Global Nuclear Medicine Revenue by Application (2016-2021)

Table 64. Global Nuclear Medicine Revenue Forecast by Application (2021-2026)

Table 65. North America Nuclear Medicine Revenue by Type (2016-2021) & (USD Million)

Table 66. North America Nuclear Medicine Revenue by Type (2021-2026) & (USD Million)

Table 67. North America Nuclear Medicine Revenue by Application (2016-2021) & (USD Million)

Table 68. North America Nuclear Medicine Revenue by Application (2021-2026) & (USD Million)

Table 69. North America Nuclear Medicine Revenue by Country (2016-2021) & (USD Million)

Table 70. North America Nuclear Medicine Revenue by Country (2021-2026) & (USD Million)

Table 71. Europe Nuclear Medicine Revenue by Type (2016-2021) & (USD Million)

Table 72. Europe Nuclear Medicine Revenue by Type (2021-2026) & (USD Million)

Table 73. Europe Nuclear Medicine Revenue by Application (2016-2021) & (USD Million)

Table 74. Europe Nuclear Medicine Revenue by Application (2021-2026) & (USD Million)

Table 75. Europe Nuclear Medicine Revenue by Country (2016-2021) & (USD Million)

Table 76. Europe Nuclear Medicine Revenue by Country (2021-2026) & (USD Million)

Table 77. Asia-Pacific Nuclear Medicine Revenue by Type (2016-2021) & (USD Million)

Table 78. Asia-Pacific Nuclear Medicine Revenue by Type (2021-2026) & (USD Million)

Table 79. Asia-Pacific Nuclear Medicine Revenue by Application (2016-2021) & (USD Million)

Table 80. Asia-Pacific Nuclear Medicine Revenue by Application (2021-2026) & (USD Million)

Table 81. Asia-Pacific Nuclear Medicine Revenue by Region (2016-2021) & (USD Million)

Table 82. Asia-Pacific Nuclear Medicine Revenue by Region (2021-2026) & (USD Million)

Table 83. South America Nuclear Medicine Revenue by Type (2016-2021) & (USD Million)

Table 84. South America Nuclear Medicine Revenue by Type (2021-2026) & (USD Million)

Table 85. South America Nuclear Medicine Revenue by Application (2016-2021) & (USD Million)

Table 86. South America Nuclear Medicine Revenue by Application (2021-2026) & (USD Million)

Table 87. South America Nuclear Medicine Revenue by Country (2016-2021) & (USD Million)

Table 88. South America Nuclear Medicine Revenue by Country (2021-2026) & (USD Million)

Table 89. Middle East & Africa Nuclear Medicine Revenue by Type (2016-2021) & (USD Million)

Table 90. Middle East & Africa Nuclear Medicine Revenue by Type (2021-2026) & (USD Million)

Table 91. Middle East & Africa Nuclear Medicine Revenue by Application (2016-2021) & (USD Million)

Table 92. Middle East & Africa Nuclear Medicine Revenue by Application (2021-2026) & (USD Million)

Table 93. Middle East & Africa Nuclear Medicine Revenue by Country (2016-2021) & (USD Million)

Table 94. Middle East & Africa Nuclear Medicine Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Nuclear Medicine Picture

Figure 2. Global Nuclear Medicine Revenue Market Share by Type in 2020

Figure 3. Tc-99

Figure 4. I-123/131

Figure 5. In-111

Figure 6. Xe-133

Figure 7. Th-201

Figure 8. Ga-67

Figure 9. Others

Figure 10. Nuclear Medicine Revenue Market Share by Application in 2020

Figure 11. Diagnostic Picture

Figure 12. Therapeutic Picture

Figure 13. Global Nuclear Medicine Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 14. Global Nuclear Medicine Revenue and Forecast (2016-2026) & (USD Million)

Figure 15. Global Nuclear Medicine Revenue Market Share by Region (2016-2026)

Figure 16. Global Nuclear Medicine Revenue Market Share by Region in 2020

Figure 17. North America Nuclear Medicine Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Europe Nuclear Medicine Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Asia-Pacific Nuclear Medicine Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. South America Nuclear Medicine Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Middle East and Africa Nuclear Medicine Revenue (USD Million) and Growth Rate (2016-2026)

Figure 22. Nuclear Medicine Market Drivers

Figure 23. Nuclear Medicine Market Restraints

Figure 24. Nuclear Medicine Market Trends

Figure 25. GE Healthcare Recent Developments and Future Plans

Figure 26. Bracco Imaging Recent Developments and Future Plans

Figure 27. Mallinckrodt Recent Developments and Future Plans

Figure 28. Lantheus Medical Imaging Recent Developments and Future Plans

Figure 29. Bayer Recent Developments and Future Plans

Figure 30. Triad Isotopes Recent Developments and Future Plans

Figure 31. Nordion Recent Developments and Future Plans

Figure 32. Jubilant Pharma Recent Developments and Future Plans

Figure 33. Eli Lilly Recent Developments and Future Plans

Figure 34. SIEMENS Recent Developments and Future Plans

Figure 35. China Isotope & Radiation Recent Developments and Future Plans

Figure 36. Dongcheng Recent Developments and Future Plans

Figure 37. Global Nuclear Medicine Revenue Share by Players in 2020

Figure 38. Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 39. Global Top 3 Players Nuclear Medicine Revenue Market Share in 2020

Figure 40. Global Top 10 Players Nuclear Medicine Revenue Market Share in 2020

Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 42. Global Nuclear Medicine Revenue Share by Type in 2020

Figure 43. Global Nuclear Medicine Market Share Forecast by Type (2021-2026)

Figure 44. Global Nuclear Medicine Revenue Share by Application in 2020

Figure 45. Global Nuclear Medicine Market Share Forecast by Application (2021-2026)

Figure 46. North America Nuclear Medicine Sales Market Share by Type (2016-2026)

Figure 47. North America Nuclear Medicine Sales Market Share by Application (2016-2026)

Figure 48. North America Nuclear Medicine Revenue Market Share by Country (2016-2026)

Figure 49. United States Nuclear Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Canada Nuclear Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Mexico Nuclear Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Europe Nuclear Medicine Sales Market Share by Type (2016-2026)

Figure 53. Europe Nuclear Medicine Sales Market Share by Application (2016-2026)

Figure 54. Europe Nuclear Medicine Revenue Market Share by Country (2016-2026)

Figure 55. Germany Nuclear Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. France Nuclear Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. United Kingdom Nuclear Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Russia Nuclear Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Italy Nuclear Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Asia-Pacific Nuclear Medicine Sales Market Share by Type (2016-2026)

Figure 61. Asia-Pacific Nuclear Medicine Sales Market Share by Application (2016-2026)

Figure 62. Asia-Pacific Nuclear Medicine Revenue Market Share by Region (2016-2026)

Figure 63. China Nuclear Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Japan Nuclear Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. South Korea Nuclear Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. India Nuclear Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Southeast Asia Nuclear Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Australia Nuclear Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. South America Nuclear Medicine Sales Market Share by Type (2016-2026)

Figure 70. South America Nuclear Medicine Sales Market Share by Application (2016-2026)

Figure 71. South America Nuclear Medicine Revenue Market Share by Country (2016-2026)

Figure 72. Brazil Nuclear Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Argentina Nuclear Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Middle East and Africa Nuclear Medicine Sales Market Share by Type (2016-2026)

Figure 75. Middle East and Africa Nuclear Medicine Sales Market Share by Application (2016-2026)

Figure 76. Middle East and Africa Nuclear Medicine Revenue Market Share by Country (2016-2026)

Figure 77. Turkey Nuclear Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Saudi Arabia Nuclear Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. UAE Nuclear Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 80. Methodology

Figure 81. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz